Feasibility and Health Effects of a 15-Week Combined Exercise Programme for Sedentary Elderly: A Randomised Controlled Trial

Table 2

Subject characteristics at baseline.

	TG (n = 30)	CG (n = 15)	Between-group
	Baseline	Baseline	P-value
CRP (mg/L)	3.6 ± 3.3	3.1 ± 3.1	0.606
eAG (mmol/L)	6.5 ± 0.4	6.5 ± 0.4	0.646
HbA1c %	5.7 ± 0.3	5.7 ± 0.2	0.761
Fasting insulin (pmol/L)	83.1 ± 45.1	79.8 ± 31.3	0.799
Total Cholesterol (mmol/L)	5.9 ± 0.8	5.4 ± 0.7	0.069
HDL-Cholesterol (mmol/L)	1.7 ± 0.5	1.8 ± 0.3	0.754
LDL-Cholesterol (mmol/L)	3.6 ± 0.8	3.2 ± 0.5	0.147
Triglycerides (mmol/L)	1.5 ± 0.9	1.2 ± 0.4	0.130
Total Chol/HDL ratio	3.69 ± 1.15	3.16 ± 0.57	0.047
Osteocalcin (µg/L)	20.4 ± 11.5	21.3 ± 7.7	0.791
P1NP (µg/L)	52.5 ± 23.2	57.7 ± 18.2	0.453
CTX-1 (µg/L)	0.4 ± 0.2	0.5 ± 0.3	0.145
Sclerostin (ng/mL)	0.9 ± 0.4	0.8 ± 0.2	0.141
Medical status
On/off medication (n)	18/12	10/5
On/off medication (%)	60/40	67/33
Healthy (%)	20	20
Lifestyle diseases
Asthma (%)	3	7
COL (%)	3	0
Hypertension (%)	20	47
Hypercholesterolemia (%)	7	20
Musculoskeletal diseases
Osteoporosis (%)	20	0
OA (%)	30	13
Herniated disc (%)	3	7
Other diseases ()	40	27

Data are presented as mean ± SD. TG: training group. CG: control group. denotes significant difference between TG and CG (P<0.05).